A detailed history of Sharp Financial Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sharp Financial Services, LLC holds 310 shares of LLY stock, worth $286,675. This represents 0.24% of its overall portfolio holdings.

Number of Shares
310
Holding current value
$286,675
% of portfolio
0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $224,709 - $281,802
310 New
310 $281 Million
Q1 2024

Aug 13, 2024

SELL
$592.2 - $792.28 $71,064 - $95,073
-120 Reduced 27.91%
310 $241 Million
Q4 2023

Aug 13, 2024

BUY
$525.19 - $619.13 $63,022 - $74,295
120 Added 38.71%
430 $251 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $879B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sharp Financial Services, LLC Portfolio

Follow Sharp Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sharp Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sharp Financial Services, LLC with notifications on news.